Evidence map›Paper›PMID 35448125›Full record

ArticleGels (Basel, Switzerland)2022

A Hydrogel as a Bespoke Delivery Platform for Stromal Cell-Derived Factor-1.

Yi Wang, Vanessa Penna, Richard J Williams, Clare L Parish, David R Nisbet

Open access · goldAbstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yi WangThe Graeme Clark Institute, The University of Melbourne, Melbourne 3010, Australia.ORCID 0000-0001-6082-8721
Vanessa PennaThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne 3052, Australia.
Richard J WilliamsInstitute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Melbourne 3216, Australia.ORCID 0000-0003-3831-8738
Clare L ParishThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne 3052, Australia.
David R NisbetThe Graeme Clark Institute, The University of Melbourne, Melbourne 3010, Australia.ORCID 0000-0002-1343-0769
The University of Melbourne · AUAustralian National University · AUDeakin University · AU

Funding

Australian Research Council DP200102870National Health and Medical Research Council GNT1135657
6 · The paper itself

Abstract

The defined self-assembly of peptides (SAPs) into nanostructured bioactive hydrogels has great potential for repairing traumatic brain injuries, as they maintain a stable, homeostatic environment at an injury site, preventing further degeneration. They also present a bespoke platform to restore function via the naturalistic presentation of therapeutic proteins, such as stromal-cell-derived factor 1 (SDF-1), expressed by meningeal cells. A key challenge to the use of the SDF protein, however, is its rapid diffusion and degradation. Here, we engineered a homeostatic hydrogel produced by incorporating recombinant SDF-1 protein within a self-assembled peptide hydrogel to create a supportive milieu for transplanted cells. Our hydrogel can concomitantly deliver viable primary neural progenitor cells and sustained active SDF-1 to support the nascent graft, resulting in increased neuronal differentiation. Moreover, this homeostatic hydrogel can ensure a healthy and larger graft core without impeding neuronal fiber growth and innervation. These findings demonstrate the regenerative potential of these hydrogels to improve the integration of grafted cells to treat neural injuries and diseases.

Indexed as

cell survivalcell transplantationhydrogellamininself-assembly peptide (SAP)stromal-cell-derived factor (SDF)

Identifiers

PMID35448125
PMCPMC9025061
OpenAlexW4224297109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.